CClinicalTrials.gg
CompletedNCT05366803WHISH STARUpdated May 9, 2022

Women's Health Initiative Silent Atrial Fibrillation Recording Study

An interventional study of Physical Activity in Atrial Fibrillation, sponsored by Stanford University. Completed at 1 site in United States. Open to female participants aged 65 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-09.

Sponsored by Stanford University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 7 months after the study started (first participant enrolled Sep 2017, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
1,257
Allocation
Randomized
Ages
65 Years to 100 Years
Sex
Female
01

Study summary

The purpose of the WHISH STAR study is to investigate whether or not those who are randomized to exercise intervention have higher rates of atrial fibrillation on review of medical records and, in a subset, on screening with a cardiac ECG patch monitor. We will also study whether those with a known history of AF have any changes in AF hospitalizations due to exercise.

Read the detailed description

The Silent Atrial Fibrillation Recording study (STAR) study is an ancillary study of the NIH-funded Women's Health Initiative Strong and Healthy (WHISH). The purpose of the Women's Health Initiative Strong and Healthy study (WHISH) is to investigate if light to moderate exercise decreases incident atrial fibrillation (AF) among women over 65 who have no baseline AF. The purpose of the STAR study is to investigate the effect of exercise intervention on incident atrial fibrillation ascertained with diagnostic codes. In a subset of women, subclinical atrial fibrillation will be ascertained with cardiac patch ECG monitoring technology (iRhythm's ZIO® XT Patch). This subgroup of WHISH study participants will undergo an 8 day cardiac patch recording at baseline, six (6) months, and one (1) year.

02

Conditions studied

  • Atrial Fibrillation

Browse trials for

03

In context

Atrial Fibrillation

3,869 studies on the registry are indexed under Atrial Fibrillation; 923 are open to participants now.

This study's enrollment of 1,257 is above the median of 144 across 2,380 interventional studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjects already enrolled in the parent WHISH study.
  • Subjects who are at high risk of developing atrial fibrillation.

Exclusion criteria

Exclusion Criteria:

  • Subjects who have had atrial fibrillation at baseline.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,257 participants (actual)

Study arms

  • Experimental
    Physical Activity Intervention

    The Physical Activity Intervention Group will receive guidance on being physically active, including aerobics, flexibility, balance, strength, and decreased sedentary time. The primary resource is the National Institute of Aging Go4Life exercise and physical activity materials. The materials are based on the United States national guidelines for physical activity for older adults. Participants will wear the Zio patch monitor (electrocardiographic loop monitoring device) for 8 days at baseline, as well as at 6 months and again at one year, for a total of 3 times.

    Behavioral: Physical Activity

  • No intervention
    Usual Activity Control

    Participants will wear the Zio patch monitor (electrocardiographic loop monitoring device) for 8 days at baseline, as well as at 6 months and again at one year, for a total of 3 times. Participants carry about their normal activities during this period.

Interventions

  • BehavioralPhysical Activity

    The PA intervention will consist of a multimodal activity program of aerobics, balance, strength, flexibility. The intervention will involve encouraging participants to increase all forms of PA throughout the day and to decrease sedentary time, such as sitting. This may include activities such as leisure sports, gardening, use of stairs instead of escalators, leisurely walks with friends, and less use of remote control devices.The intervention is conducted primarily by mail with website support and resources available.

06

What researchers measure

Primary outcomes

  1. Change in Incidence of Atrial Fibrillation Due to Exercise

    Time frame: One year

  2. Number of Participants without Clinically Diagnosed Atrial Fibrillation (AF) Found to have Silent AF with Prolonged ECG Patch Monitoring

    Time frame: One year

07

Study locations

1 site
  • Stanford University School of Medicine
    Stanford, California 94305, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05366803
Lead sponsor
Stanford University
Responsible party
Marco Perez (Associate Professor of Medicine (Cardiovascular Medicine), Stanford University) — Principal investigator
First posted
May 9, 2022
Start date
Sep 8, 2017
Primary completion
Feb 11, 2020
Completion
Feb 11, 2020
Last update
May 9, 2022

Study contacts

Marco Perez, MD
principal investigator · Stanford University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion